Journal Information
Vol. 2. Issue 2.
Pages 64-69 (March - April 2006)
Share
Share
Download PDF
More article options
Vol. 2. Issue 2.
Pages 64-69 (March - April 2006)
Originales
Full text access
Adaptación transcultural y validación de una versión en español de un instrumento específico para medir calidad de vida relacionada con la salud en pacientes con espondilitis anquilosante: el ASQoL
Cross-cultural adaptation and validation of a Spanish version of a specific instrument to measure health-related quality of life in patients with ankylosing spondylitis
Visits
11196
R. Ariza-Ariza
Corresponding author
rariza@supercable.es

Correspondencia: Dr. R. Ariza-Ariza. Servicio de Reumatología. Hospital Universitario Virgen Macarena. Avda. Dr. Fedriani, 3. 41009 Sevilla. España.
, B. Hernández-Cruz, G. López-Antequera, F.J. Toyos, F. Navarro-Sarabia
Servicio de Reumatología. Hospital Universitario Virgen Macarena. Sevilla. España
This item has received
Article information
Objetivo

Adaptación transcultural y validación de la versión en español del Ankylosing Spondylitis Quality of Life Questionnaire (ASQoL).

Pacientes y métodos

Estudio transversal con prueba testretest. Se incluyeron pacientes con espondilitis anquilosante (EA). Se realizó adaptación transcultural de la versión original del ASQoL mediante traducción y retrotraducción. Se estudiaron validez de constructo, consistencia interna, reproducibilidad y factibilidad. El análisis estadístico se realizó con el coeficiente de correlación de Spearman, la pruebas U de Mann- Whitney y Kruskal-Wallis, el coeficiente alfa de Cronbach y el estadístico kappa.

Resultados

Se incluyeron 54 pacientes, 37 (68,5%) varones, con edad (promedio±DE) 40,5 ± 10,5 años. El ASQoL tuvo una puntuación de 6,8±4,7 (mediana, 7; intervalo, 0-17) y presentó correlaciones altas con los componentes globales físico (rho = 0,79) y mental (0,69) del SF-36 y con los dominios de dolor (0,82), vitalidad (0,75) y rol físico (0,68), así como con la mayoría de variables representativas de la EA. Las puntuaciones del ASQoL fueron significativamente diferentes entre los pacientes con distintos niveles de respuesta en el perfil de salud del EuroQol. El ASQoL tuvo un coeficiente alfa de Cronbach de 0,86. La prueba test-retest se realizó en 10 pacientes con un intervalo de 24 h y tuvo una kappa entre 1 (12 preguntas) y 0,57 (1 pregunta) con rho de 0,98 para las puntuaciones globales. El tiempo empleado osciló entre 2 y 5 min.

Conclusiones

La versión en español del ASQoL es válida, fiable y factible de aplicar en nuestro medio para medir la calidad de vida de los pacientes con EA.

Palabras clave:
Espondilitis anquilosante
Calidad de vida
ASQoL
Objective

To make a cross-cultural adaptation and validation of a version in Spanish of the Ankylosing Spondylitis Quality of Life Questionnaire (ASQoL) for assessing the health-related quality of life (HRQL) of patients with Ankylosing Spondylitis (AS).

Patients and methods

A cross-sectional study with test-retest. AS patients (modified New York criteria) were included. Cross-cultural adaptation was done. Construct validity was assessed comparing the ASQoL scores with the SF-36 and EuroQol scores and diseaserelated variables. Internal consistency and reliability (test-retest) were assessed. Feasibility was assessed by the time spent to complete the questionnaire and the number of items without answer. Spearman correlation coefficient, Mann-Whitney U test, and Kruskal-Wallis test were used in the statistical analysis. Cronbach¿alpha coefficient and statistic kappa were used for assessing internal consistency and reliability.

Results

Fifty-four patients, 37 males (68.5%), with age (mean±SD) 40.5±10.5 years, were included. The ASQoL global score was 6.8±4.7 (median, 7; range, 0-17). The ASQoL scores had high correlations with physical (rho = 0.79) and mental (0.69) SF-36 components, the SF-36 domains pain (0.82), vitality (0.75), and role-physical (0.68), and the most of the disease-related variables. The ASQoL scores were significantly different between patients with different response levels in the health profile of the EuroQol. The Cronbach¿alpha coefficient was 0.86. The reliability had kappa = 1 in 12 items and rho = 0.98. The time spent to complete the ASQoL was from 2 to 5 minutes and there only was a missing answer in one patient.

Conclusion

The Spanish ASQoL is valid, reliable, and feasible instrument for assessing the HRQL of the AS patients.

Key words:
Ankylosing spondylitis
Quality of life
ASQoL
Full text is only aviable in PDF
Bibliografía
[1.]
R. Ariza-Ariza, B. Hernández-Cruz, F. Navarro-Sarabia.
Physical function and health related quality of life of Spanish patients with ankylosing spondylitis.
Arthritis Rheum, 49 (2003), pp. 483-487
[2.]
D. Van der Heide, N. Bellamy, A. Calin.
Preliminary core sets for endpoints in AS.
J Rheumatol, 24 (1997), pp. 2225-2229
[3.]
D.M.F.M. Van der Heijde, S.M. Van der Linden, N. Bellamy, A. Calin, M. Dougados, M.A. Khan.
Which domains should be included in a core set for endpoints in ankylosing spondylitis? Introduction to the ankylosing spondylitis module of OMERACT IV.
J Rheumatol, 26 (1999 Apr), pp. 945-947
[4.]
J.E. Ware, C.D. Sherbourne.
The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.
Med Care, 30 (1992), pp. 473-481
[5.]
J. Alonso, L. Prieto, J.M. Antó.
La versión española del SF-36 Health Survey (cuestionario de salud SF-36): un instrumento para la medida de los resultados clínicos.
Med Clin (Barc), 104 (1995), pp. 771-776
[6.]
M.M. Ward.
Health related quality of life in ankylosing spondylitis. A survey of 175 patients.
Arthritis Care Res, 12 (1999), pp. 247-255
[7.]
A.M. Chorus, H.S. Miedema, A. Boonen, S. Van der Linden.
Quality of life and work in patients with rheumatoid arthritis and ankylosing spondylitis of working age.
Ann Rheum Dis, 62 (2003), pp. 1178-1184
[8.]
J. Brandt, H. Haibel, D. Cornely, W. Golder, J. González, J. Reddig, et al.
Successful treatment of active ankylosing spondylitis with the anti tumor necrosis factor alpha monoclonal antibody infliximab.
[9.]
J. Braun, J. Brandt, J. Listing, A. Zink, R. Alten, W. Golder, et al.
Treatment of active ankylosing spondylitis with infliximab: a randomised, controlled, multicentre trial.
Lancet, 359 (2002), pp. 1187-1193
[10.]
J. Brandt, A. Khariouzov, J. Listing, H. Haibel, H. Sorensen, L. Grassnickel, et al.
Six-month results of a double-blind, placebo-controlled trial of etanercept treatment in patients with active ankylosing spondylitis.
Arthritis Rheum, 48 (2003), pp. 1667-1675
[11.]
C. Jenkinson, R. Layte.
Development and testing of the UK SF-12 (short form health survey).
J Health Serv Res Policy, 2 (1997), pp. 14-18
[12.]
K.L. Haywood, A.M. Garrat, K. Dziedzic, P.T. Dawes.
Generic measures of health related quality of life in ankylosing spondylitis: reliability, validity and responsiveness.
Rheumatology, 41 (2002), pp. 1380-1387
[13.]
The EuroQol Group.
A new facility for the measurement of health-related quality of life.
Health Policy, 16 (1990), pp. 199-208
[14.]
R. Booh, with the EuroQol Group.
EuroQol: the current state of the play.
Health Policy, 37 (1996), pp. 53-72
[15.]
X. Badía, M. Roset, S. Montserrat, M. Herdman, A. Segura.
La versión española del EuroQol: descripción y sus aplicaciones. Escala Europea de Calidad.
Med Clin (Barc), 112 (1999), pp. 79-85
[16.]
S.M. Hunt, S.P. McKenna, J. McEwen, E.M. Backett, J. Williams, E. Papp.
A quantitative approach to perceived health status: a validation study.
J Epidemiol Community Health, 34 (1980), pp. 281-286
[17.]
J. Alonso, L. Prieto, J.M. Antó, The Spanish versión of the Nottingham Health Profile.
A review of adaptation and instrument characteristics.
Qual Life Res, 3 (1994), pp. 385-393
[18.]
E. Bostan, P. Borman, H. Bodur, N. Barça.
Functional disability and quality of life in patients with ankylosing spondylitis.
Rheumatol Int, 23 (2003), pp. 121-126
[19.]
K.L. Haywood, A. Garratt, K. Dziedzic, P.T. Dawes.
Patient centered assessment of ankylosing spondylitis-specific health related quality of life: evaluation of the Patient Generated Index.
J Rheumatol, 30 (2003), pp. 764-773
[20.]
L.C. Doward, A. Spoorenberg, S.A. Cook, D. Whalley, P.S. Helliwell, L.S. Kay, et al.
Development of the ASQoL: a quality of life instrument specific to ankylosing spondylitis.
Ann Rheum Dis, 62 (2003), pp. 20-26
[21.]
H. Marzo-Ortega, D. McGonagle, P. O’Connor, P. Emery.
Efficacy of etanercept in the treatment of the entheseal patology in resistant spondylarthropathy: a clinical and magnetic resonante imaging study.
Arthritis Rheum, 44 (2001), pp. 2212-2217
[22.]
K.L. Haywood, A. Garratt, K. Jordan, K. Dziedzic, P.T. Dawes.
Disease-specific, patient-assessed measures of health outcome in ankylosing spondylitis.
Rheumatology (Oxford), 41 (2002), pp. 1295-1302
[23.]
A.L. Tan, H. Marzo-Ortega, P. O’Connor, A. Fraser, P. Emery, D. McGonagle.
Efficacy of anakinra in active ankylosing spondylitis: a clinical and magnetic resonant imaging study.
Ann Rheum Dis, 63 (2004), pp. 1041-1045
[24.]
K.L. Haywood, A. Garratt, K. Jordan, K. Dziedzic, P.T. Dawes.
Spinal mobility in ankylosing spondylitis: reliability, validity, and responsiveness.
Rheumatology (Oxford), 43 (2004), pp. 750-757
[25.]
S.M. Van der Linden, H.A. Valkenburg, A. Cats.
Evaluation of diagnostic criteria for ankylosing spondylitis: a proposal for modification of the New York criteria.
Arthritis Rheum, 27 (1984), pp. 361-368
[26.]
R. Ariza-Ariza, B. Hernández Cruz, F. Navarro Sarabia.
La versión española del BASDAI es fiable y refleja adecuadamente la actividad de la enfermedad en enfermos españoles con espondilitis anquilosante.
Rev Esp Reumatol, 31 (2004), pp. 372-378
[27.]
T.R. Jenkinson, P.A. Malloire, H.C. Whithelok, L.G. Kennedy, S.L. Garrett, A. Calin.
Defining spinal mobility in ankylosing spondylitis (AS): the Bath AS Metrology Index.
J Rheumatol, 21 (1994), pp. 1694-1698
[28.]
S.D. Jones, J. Porter, S.L. Garrett, L.G. Kennedy, H.C. Whithelok, A. Calin.
A new scoring for the Bath Ankylosing Spondylitis Metrology Index (BASMI).
J Rheumatol, 22 (1995), pp. 1609
Copyright © 2006. Elsevier España S.L Barcelona
Download PDF
Idiomas
Reumatología Clínica (English Edition)
Article options
Tools
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?